MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 05-23-2026
Chembio Diagnostics ROA Ratio 2011-2026 | CEMI
Annual ROA Ratio Chembio Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -37.2 | -46.28 | -39.33 | -24.54 | -19.23 | -38.35 | -64.87 | -11.52 | -4.55 | 2.17 | 5.43 | 40.09 | 27.66 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 40.09 | -64.87 | -16.19 |
Quarterly ROA Ratio Chembio Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -37.14 | -44.72 | -52.23 | -47.67 | -33.7 | -41.61 | -44.1 | -35.58 | -27.74 | -34.39 | -34.05 | -30.17 | -20.4 | -28.68 | -27.9 | -22.6 | -16.42 | -28.45 | -23.21 | -28.43 | -33.89 | -34.29 | -40.68 | -95.38 | -89.15 | -79.83 | -72.32 | -9.36 | -10.54 | -8.56 | -7.25 | -5.38 | -2.7 | 0.25 | 0.36 | 2.78 | 3.74 | 1.93 | 0.83 | 4.5 | 2.68 | 7.39 | 11.51 | 8.75 | 6.1 | 4.71 | 2.31 | -0.92 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.51 | -95.38 | -22.74 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
11.3 | $ 115.08 | 0.1 % | $ 35 B | USA |
 |
Celcuity
CELC
|
-37.95 | $ 134.26 | -2.87 % | $ 6.28 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 9.11 | 79.68 % | $ 12.1 M | USA |
 |
Castle Biosciences
CSTL
|
-4.18 | $ 19.69 | -2.28 % | $ 571 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-175.25 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Fulgent Genetics
FLGT
|
-4.99 | $ 17.67 | 3.27 % | $ 544 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 21.54 | -0.42 % | $ 1.15 B | USA |
 |
Guardant Health
GH
|
-20.67 | $ 119.85 | 0.76 % | $ 15 B | USA |
 |
Check-Cap Ltd.
CHEK
|
55.3 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.8 | -1.1 % | $ 7.96 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 113.85 | -2.51 % | $ 9.39 B |  Irlanda |
 |
Illumina
ILMN
|
-19.4 | $ 145.23 | 0.56 % | $ 23.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-194.25 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 100.06 | -2.85 % | $ 6.75 B | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 156.73 | -2.23 % | $ 7.77 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
23.41 | $ 1 101.33 | -0.16 % | $ 22.7 B |  Schweiz |
 |
Medpace Holdings
MEDP
|
22.84 | $ 429.11 | -0.85 % | $ 12.4 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 9.27 | 0.43 % | $ 1.19 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 19.04 | -0.21 % | $ 426 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Natera
NTRA
|
-39.28 | $ 200.91 | -1.12 % | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-51.8 | $ 3.85 | 0.79 % | $ 357 M | USA |
 |
Personalis
PSNL
|
-24.32 | $ 8.94 | 5.55 % | $ 798 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
3.33 | $ 26.94 | -0.04 % | $ 25.5 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-54.72 | $ 6.43 | 1.42 % | $ 268 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
3.71 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-83.65 | $ 2.47 | -0.8 % | $ 5.67 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 258.45 | -0.57 % | $ 21.5 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 64.87 | 7.1 % | $ 3.88 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 448.18 | -0.02 % | $ 169 B | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 338.64 | -1.09 % | $ 20.2 B | USA |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.65 | 7.49 % | $ 233 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.14 | 2.7 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 192.88 | -1.19 % | $ 21.4 B | USA |